Skip to main content

GE Healthcare, GlaxoSmithKline Ink Data-Integration Deal

NEW YORK, Nov. 1 (GenomeWeb News) - GE Healthcare will help GlaxoSmithKline develop an informatics system to integrate data from internal and external drug-discovery R&D sources, the companies said today.

 

Under the deal, GlaxoSmithKline will be able to use GE Healthcare's GeneticXchange's DiscoveryHub data- and information-integration software in its genetics, discovery, and pre-clinical-development R&D groups.

 

Additionally, the deal calls for GE Healthcare and GlaxoSmithKline to design, develop, and support next-generation DiscoveryHub technology.

Financial terms of the deal were not disclosed.

 

For additional details about the deal, see this week's issue of BioInform, GenomeWeb News' sister publication.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.